Overall survival with darolutamide vs placebo in combination with androgen-deprivation therapy (ADT) and docetaxel: A sensitivity analysis from ARASENS accounting for subsequent therapy.
| Autor: | Shore, Neal D., Tombal, Bertrand F., Hussain, Maha H. A., Saad, Fred, Fizazi, Karim, Sternberg, Cora N., Crawford, E. David, Fralich, Todd, Li, Rui, Smith, Matthew Raymond |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p166-166, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|